The company will partner with clients to develop and optimize pharmaceutical engineering processes and technologies by coupling fundamental cellular processes with the optimal cell environment for each phase of production.
The company plans to offer new technologies and equipment proven to improve biotherapeutic and vaccine production.
Bend Research senior vice president Lisa Graham told Pharmabiz that the campaign is grounded in science and engineering fundamentals, with a focus on applying macro engineering approaches to leverage an understanding of complex cell-biology.
"We’ve validated this approach in our small-molecules business and we’re now uniquely positioned to bring this valuable experience to the broader biotherapeutics market," Graham added.